ANTICORPS MONOCLONAUX BLOQUANTS DIRIGÉS CONTRE AGR2 ET SON RÉCEPTEUR C4.4A
- 专利权人:
- The University of Texas System;Board of Regents
- 发明人:
- 申请号：
- EP15766358.4
- 公开号：
- EP3191525B1
- 申请日:
- 2015.09.08
- 申请国别(地区):
- EP
- 年份:
- 2019
- 代理人:
- 摘要：
- Provided herein are monoclonal antibodies that recognize, bind to, and block interactions of other molecules with AGR2 and C4.4A. Also provided herein are methods of using anti-AGR2 and anti-C4.4A antibodies to treat cancer.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- ANTICORPS MONOCLONAUX BLOQUANTS DIRIGES CONTRE AGR2 ET SON RECEPTEUR C4.4A
- BLOCKING MONOCLONAL ANTIBODIES TO AGR2 AND ITS RECEPTOR C4.4A
- Blocking monoclonal antibodies to AGR2 and its receptor C4.4A
- MÉTHODES DE TRAITEMENT DU CANCER À L'AIDE D'ANTICORPS MONOCLONAUX DIRIGÉS CONTRE AGR2 ET C4.4A
- isolated monoclonal antibodies； monoclonal antibodies or antigen binding fragments thereof； composition； isolated polynucleotide molecules； recombinant polypeptide； polypeptides； host cell； method of making an antibody； use of an agent for treating cancer in a patient； uses of monoclonal antibody or antigen-binding fragment thereof for the treatment of a subject suffering from cancer； use of monoclonal antibody to treat a subject suffering from cancer； a composition comprising an agr2 binding antibody； a composition comprising a c4.4a binding antibody； a composition comprising an agr2 binding
